Skip to main content

$0.007 (0%)

High

$0.01

Low

$0.01

Trades

47

Turnover

$23,686

Volume

3,636,136
30 June 2023 at 4:10pm
Register to track ME1 and receive email alerts.

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Expand Company Description

ME1 Announcements on Price Chart

Latest Announcements

Headline Date
Appendix 3G 30 June 2023 at 7:25pm
Appendix 2A 30 June 2023 at 7:25pm
Appendix 2A 26 June 2023 at 7:25pm
Appendix 3H 26 June 2023 at 4:55pm
Appendix 2A 21 June 2023 at 7:35pm
Change in substantial holding 21 June 2023 at 6:40pm
Appendix 3B - Amendment 19 June 2023 at 7:25pm
Appendix 3B 19 June 2023 at 7:20pm
Appendix 3G 15 June 2023 at 7:25pm
Appendix 2A 15 June 2023 at 7:05pm
Disclosure Document 15 June 2023 at 4:00pm
Appendix 3B 14 June 2023 at 4:10pm
Appendix 2A 14 June 2023 at 4:10pm
Debt Conversions and Extensions 14 June 2023 at 10:30am
Change of Company Name and ASX Code 13 June 2023 at 9:00am
Register to track ME1 and receive email alerts.